Key result
Sternal intraosseous and IV amiodarone reduce time to peak concentration by ~54% vs tibial delivery.
Why the study?
Does sternal intraosseous administration of amiodarone improve pharmacokinetics compared to tibial intraosseous or intravenous routes in a swine model of ventricular fibrillation?
RCT (n=21)
Randomly assigned
Does sternal intraosseous administration of amiodarone improve pharmacokinetics compared to tibial intraosseous or intravenous routes in a swine model of ventricular fibrillation?
In a swine model of ventricular fibrillation with ongoing CPR, sternal intraosseous administration of amiodarone achieved maximum plasma concentration significantly faster than the tibial route, performing comparably to intravenous administration.
Answers are grounded in this paper and cite their sources.
SIO amiodarone reaches peak levels faster than TIO in swine VF; leaves open any human cardiac arrest advantage over IV.
OBJECTIVE: The pharmacokinetics of IO administered lipid soluble amiodarone during ventricular fibrillation (VF) with ongoing CPR are unknown. This study measured mean plasma concentration over 5 minutes, maximum plasma concentration (Cmax), and time to maximum concentration (Tmax) of amiodarone administered by the sternal IO (SIO), tibial IO (TIO), and IV routes in a swine model of VF with ongoing CPR. METHODS: Twenty-one Yorkshire-cross swine were randomly assigned to three groups: SIO, TIO, and IV. Ventricular fibrillation was induced under general anesthesia. After 4 minutes in VF, 300 mg amiodarone was administered as indicated by group assignment. Serial blood specimens collected at 30, 60, 90, 120, 150, 180, 240, and 300 seconds were analyzed using high performance liquid chromatography with tandem mass spectrometry. RESULTS: The mean plasma concentration of IV amiodarone over 5 minutes was significantly higher than the TIO group at 60 seconds (P = 0.02) and 90 seconds (P = 0.017) post-injection. No significant differences in Cmax between the groups were found (P <0.05). The Tmax of amiodarone was significantly shorter in the SIO (99 secs) and IV (86 secs) groups compared to the TIO group (215 secs); P = 0.002 and P = 0.002, respectively. CONCLUSIONS: The SIO and IV routes of amiodarone administration were comparable. The TIO group took nearly three times longer to reach Tmax than the SIO and IV groups, likely indicating depot of lipid-soluble amiodarone in adipose-rich tibial yellow bone marrow. The SIO route was more effective than the TIO route for amiodarone delivery in a swine model of VF with ongoing CPR. Further investigations are necessary to determine if the kinetic differences found between the SIO and TIO routes in this study affect survival of VF in humans.
No takes yet. Share an insight, caveat, or question.
Burgert et al. (2017) conducted an RCT in Ventricular fibrillation with ongoing CPR (n=21). Amiodarone via sternal intraosseous (SIO) route vs. Tibial intraosseous (TIO) and intravenous (IV) routes was evaluated on Time to maximum concentration (Tmax) (p=0.002). Sternal intraosseous and intravenous amiodarone achieved shorter time to maximum concentration compared to the tibial route.
Synapse has enriched 10 related papers. Consider them for comparative context: